Glenmark Pharmaceuticals informs about media release

21 Mar 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release today titled ‘Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1690.95 -2.35 (-0.14%)
01-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.